Question 1

What are the most cited papers from Catalyst Pharmaceuticals (United States)?

Accepted Answer

The most cited paper from Catalyst Pharmaceuticals (United States) is "Habits and Goals in Human Behavior: Separate but Interacting Systems" (Wendy Wood, Asaf Mazar, David T. Neal, 2021), with 145 citations. Next come "Computational methods for case-cohort studies" (128) and "(1S, 3S)-3-Amino-4-difluoromethylenyl-1-cyclopentanoic Acid (CPP-115), a Potent γ-Aminobutyric Acid Aminotransferase Inactivator for the Treatment of Cocaine Addiction" (52).

Question 2

Which research topics does Catalyst Pharmaceuticals (United States) publish most on?

Accepted Answer

By volume in 2022-now: Autoimmune Neurological Disorders and Treatments, Myasthenia Gravis and Thymoma, Peripheral Neuropathies and Disorders and Pain Mechanisms and Treatments.

Question 3

Which fields of science does Catalyst Pharmaceuticals (United States) work in?

Accepted Answer

In all years, 59% of research at Catalyst Pharmaceuticals (United States) is in Health Sciences, 30% in Life Sciences. Its largest fields are Medicine (59%), Neuroscience (17%), Biochemistry, Genetics and Molecular Biology (7%). It does 1.6× the world's share of Health Sciences.

Question 4

Is Catalyst Pharmaceuticals (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 78% higher than in 2018-2021.